Q4 FY2025 · Press release
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1 · 2 pages
Read Sarepta Therapeutics, Inc.'s results firsthand
Preview this press release
Create a free account to start reading
Full documents are included with Professional